Royalty Pharma 

Royalty Pharma 

Quarterly Financials

Values in thousands2026-09-302026-06-302026-03-312025-12-31
Revenue
$690,000
$674,141
$630,576
$621,990
Gross Profit
628,000
405,925
629,405
621,990
EBITDA
357,000
176,397
563,149
451,280
EBIT
357,131
175,103
561,978
450,084
Net Income
145,000
17,883
295,000
214,205
Net Change In Cash
690,000
674,141
630,576
621,990
Free Cash Flow
686,076
686,155
760,539
827,148
Cash
513,657
812,000
586,395
619,000
Basic Shares
556,896
556,896
559,611
559,611

Annual Financials

Values in thousands2025-12-312024-12-312023-12-312022-12-31
Revenue
$2,378,193
$2,263,576
$2,354,554
$2,237,215
Gross Profit
2,378,193
2,263,576
2,354,554
2,237,215
EBITDA
1,635,708
1,556,325
1,887,275
423,695
EBIT
1,631,856
1,292,444
1,492,150
418,025
Net Income
770,947
858,983
1,134,834
42,832
Net Change In Cash
2,378,193
2,263,576
2,354,554
2,237,215
Cost of Revenue
169,703
Free Cash Flow
2,489,823
2,768,986
2,987,802
4,185,132
Cash
618,696
929,026
477,010
1,710,751
Basic Shares
559,611
594,000
602,900
564,931

Earnings Calls

QuarterEPS
2026-09-30
$1.21
2026-06-30
$1.32
2026-03-31
$1.30
2025-12-31
$1.47